SCHEMBL13440469

SCHEMBL13440469

Cc1cccc(-c2ccc3c(c2)[C@]2(CC3)CC(=O)N(C)C(=N)N2)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PGR P06401 1/20 0.41
PARP10 Q53GL7 1/20 0.40
PARP11 Q9NR21 1/20 0.40
FYN P06241 1/20 0.39
CLK4 Q9HAZ1 1/20 0.39
DYRK1B Q9Y463 1/20 0.39
ALDH1A1 P00352 4/20 0.37
HTT P42858 2/20 0.37
MAPT P10636 2/20 0.37
LMNA P02545 1/20 0.37
BACE1 P56817 6/20 0.33
SIRT2 Q8IXJ6 1/20 0.32
KDM4E B2RXH2 1/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
PDE5A O76074 1/20 0.32
PDE1A P54750 1/20 0.32
PDE1B Q01064 1/20 0.32
PDE4D Q08499 1/20 0.32
PDE7A Q13946 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7534860 0.88 PGR (0.42) PGRPARP10PARP11BACE1
SCHEMBL7555003 0.88 PARP10 (0.40) PGRPARP10PARP11BACE1
SCHEMBL7569767 0.86 BACE1 (0.45) PGRBACE1MEN1KMT2A
SCHEMBL8197840 0.85 BACE1 (0.43) PARP10PARP11HTTBACE1MEN1
SCHEMBL7541624 0.85 BACE1 (0.43) PARP10PARP11HTTBACE1MEN1
SCHEMBL7541254 0.84 CYP11B1 (0.48) BACE1PDE5APDE1APDE1BPDE4D
SCHEMBL7542913 0.82 PARP10 (0.38) PGRPARP10PARP11BACE1PDE5A
SCHEMBL7535531 0.82 PGR (0.42) PGRPARP10PARP11BACE1PDE5A
SCHEMBL17715727 0.82 ALDH1A1 (0.38) ALDH1A1HTTMAPTLMNAKDM4E
SCHEMBL12498789 0.81 PDE7A (0.34) PGRBACE1PDE5APDE1APDE1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7700603-B2 Heterocyclic aspartyl protease inhibitors SCHERING CORPORATION (US) 2010-04-20 US disclosed
EP-1838304-B1 HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS SCHERING CORP (US) 2009-08-19 EP disclosed